mounjaro glp 1 gip LLY -0.60% today as Lilly's (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes Mounjaro Tirzepatide Glp-1 Gip Receptor

Intersil Releases New USB-C Buck-Boost Battery Charger IC New ISL9237 Provides a Single-Chip Solution for Two-Way Power Delivery Through The USB Connection Intersil have introduced the industry's first buck-boost battery charger that supports two-way power delivery in ultrabooks, tablets and power banks using the reversible USB Type-C connector

If a drug with similar efficacy requires a shot every two weeks instead of every week, more patients may persist with therapy long enough to experience meaningful clinical benefit

Effects of atrial natriuretic peptide on glomerular filtration rate in essential hypertension: a radionuclide study

AOD-9604 The Lipolytic Fragment AOD-9604 is derived from the C-terminal fragment of human growth hormone (residues 177191)